XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Net Sales $ 16,462 $ 16,281 $ 50,590 $ 50,329
Cost of Products Sold 8,427 8,384 25,830 25,362
Selling, General and Administrative Expense 4,806 4,688 14,081 14,191
Operating Income 3,229 3,209 10,679 10,776
Interest Expense 131 133 398 370
Interest Income 52 69 168 184
Other Non-operating Income/(Loss), Net 128 108 685 447
Earnings/(Loss) from Continuing Operations Before Income Taxes 3,278 3,253 11,134 11,037
Income Taxes on Continuing Operations 502 713 1,931 3,066
Net Earnings 2,776 2,540 9,203 7,971
Net Income (Loss) Attributable to Noncontrolling Interest 31 29 65 112
Net Earnings Attributable to Procter & Gamble $ 2,745 $ 2,511 $ 9,138 $ 7,859
Basic Net Earnings Per Common Share        
Basic Net Earnings Per Common Share [1],[2] $ 1.07 $ 0.97 $ 3.58 $ 3.02
Diluted Net Earnings Per Common Share        
Diluted Net Earnings Per Common Share [1],[2] $ 1.04 $ 0.95 $ 3.48 $ 2.94
Diluted Weighted Average Common Shares Outstanding 2,637.7 2,645.6 2,624.3 2,668.6
[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.